Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An update on animal models of liver fibrosis
ShuTing Wu, Xinxin Wang, WenBo Xing, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

A Guide to Pathophysiology, Signaling Pathways, and Preclinical Models of Liver Fibrosis
Marjia Sultana, Md Asrarul Islam, Rhema Khairnar, et al.
Molecular and Cellular Endocrinology (2025), pp. 112448-112448
Closed Access | Times Cited: 3
Activation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease
Marta Belka, Aleksandra Gostyńska, Maciej Stawny, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11213-11213
Open Access | Times Cited: 9
Time-course of changes in fibrous components in a thioacetamide-induced liver fibrosis model in cynomolgus monkeys
Masashi Takahashi, Mihoko Ono, Satoru Kajikawa, et al.
Journal of Toxicologic Pathology (2025) Vol. 38, Iss. 2, pp. 155-160
Open Access | Times Cited: 1
Research progress on rodent models and its mechanisms of liver injury
Jingxin Mao, Lihong Tan, Tian Cheng, et al.
Life Sciences (2023) Vol. 337, pp. 122343-122343
Open Access | Times Cited: 12
Fucoxanthin Enhances the Antifibrotic Potential of Placenta-derived Mesenchymal Stem Cells in a CCl4-induced Mouse Model of Liver
Vasilii N. Slautin, Konstantin Konyshev, I. V. Gavrilov, et al.
Current Stem Cell Research & Therapy (2024) Vol. 19, Iss. 11, pp. 1484-1496
Closed Access | Times Cited: 4
Adipose Tissue and Umbilical Cord Tissue: Potential Sources of Mesenchymal Stem Cells for Liver Fibrosis Treatment
Hafiz Ghufran, Maryam Azam, Azra Mehmood, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 14, Iss. 4, pp. 101364-101364
Closed Access | Times Cited: 4
Lactoferrin as a therapeutic agent for attenuating hepatic stellate cell activation in thioacetamide-induced liver fibrosis
Tzu-Yu Pu, Kai-Cheng Chuang, Min‐Che Tung, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116490-116490
Open Access | Times Cited: 4
Delivery of Eicosapentaenoic acid-loaded cellulose nanocrystal alleviates liver fibrosis via modulating phospholipids and apoptotic regulators
Jihan Hussein, Dalia Medhat, Mona El Bana, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 97, pp. 105796-105796
Closed Access | Times Cited: 4
PI3K/Akt Pathway involvement in hepatic inflammation: In silico evaluation of silybum marianum and a research proposal for homeopathic Carduus marianus
Dal Pozzo Lisa
International Journal of Homoeopathic Sciences (2025) Vol. 9, Iss. 1, pp. 167-183
Open Access
In Vivo and In Vitro Models of Hepatic Fibrosis for Pharmacodynamic Evaluation and Pathology Exploration
Yanting Hu, Zhongrui Zhang, Akida Adiham, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 696-696
Open Access
Role of hepatocellular senescence in the development of hepatocellular carcinoma and the potential for therapeutic manipulation
Pramudi Wijayasiri, Stuart Astbury, G Needham, et al.
Human Cell (2025) Vol. 38, Iss. 3
Open Access
Pirfenidone encapsulated in succinylated gelatin-coated liposomes exhibits sustained antifibrotic effects in in vitro models of renal, pulmonary, and hepatic fibrosis
Kohei Togami, Yukimune Kanehira, Yuki Nakamura, et al.
Journal of Pharmaceutical Sciences (2025), pp. 103819-103819
Closed Access
A thioacetamide-induced liver fibrosis model for pre-clinical studies in microminipig
Kotaro Nishi, Hiroshi Yagi, Mana Ohtomo, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Fibrosis‐on‐Chip: A Guide to Recapitulate the Essential Features of Fibrotic Disease
Emma M. Streutker, Utku Devamoglu, Madelon C Vonk, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 21
Open Access | Times Cited: 3
A rule-based multiscale model of hepatic stellate cell plasticity: Critical role of the inactivation loop in fibrosis progression
Matthieu Bouguéon, Vincent Legagneux, Octave Hazard, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 7, pp. e1011858-e1011858
Open Access | Times Cited: 3
Single and combined strategies for mesenchymal stem cell exosomes alleviate liver fibrosis: a systematic review and meta-analysis of preclinical animal models
Xiaolei Zhou, Yan Xu, Xuesong Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Preclinical liver toxicity models: advantages, limitations and recommendations
Devaraj Ezhilarasan, Sivanesan Karthikeyan, Mustapha Najimi, et al.
Toxicology (2024), pp. 154020-154020
Closed Access | Times Cited: 2
Quercetin-Loaded Melanin Nanoparticles Decorated with Collagenase Mediates Synergistic Immunomodulation and Restores Extracellular Matrix Homeostasis in Liver Fibrosis
Tingting Li, Weihua Fu, Xueqi Li, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 2
The combination of tetracyclines effectively ameliorates liver fibrosis via inhibition of EphB1/2
Yueqing Han, Haoxin Song, Yanshan Li, et al.
International Immunopharmacology (2023) Vol. 126, pp. 111261-111261
Closed Access | Times Cited: 6
A rule-based multiscale model of hepatic stellate cell plasticity: critical role of the inactivation loop in fibrosis progression
Matthieu Bouguéon, Vincent Legagneux, Octave Hazard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Hepatocyte-specific loss of DDB1 attenuates hepatic steatosis but aggravates liver inflammation and fibrosis in MASH
Qiuxia Gu, Yushun Chang, Yan Jin, et al.
Hepatology Communications (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 1
STA-9090 in combination with a statin exerts enhanced protective effects in rats fed a high-fat diet and exposed to diethylnitrosamine and thioacetamide
A. M. Abdelhamid, Sameh Saber, Rabab S. Hamad, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Selecting preclinical animal models in hepatology research: A call for uniform guidelines
Devaraj Ezhilarasan, Mustapha Najimi
Laboratory Investigation (2024) Vol. 105, Iss. 1, pp. 102179-102179
Closed Access | Times Cited: 1
Community Series - Liver Fibrosis and MAFLD: from Molecular Aspects to Novel Pharmacological Strategies, Volume II

Frontiers research topics (2024)
Open Access
A rat model of cirrhosis with well-differentiated hepatocellular carcinoma induced by thioacetamide
Zhiping Hu, Takeshi Kurihara, Yiyue Sun, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top